This document compiles ten studies highlighting potential health risks of glyphosate, including links to autism-like behaviors, Alzheimer’s, gut dysbiosis, liver disease, and cancer. It also raises concerns about transgenerational effects and the toxicity of surfactants in glyphosate formulations.
Bayer’s 2024 Annual Report reveals that despite claims of potentially pulling glyphosate from U.S. markets, the company continues to invest in and profit heavily from the herbicide. Bayer’s threat is a bluff intended to pressure lawmakers for legal immunity, as glyphosate remains too lucrative to abandon.
This document details a history of deception by pesticide manufacturers like Bayer/Monsanto and ChemChina, highlighting their practices of falsifying research, suppressing safety data, and influencing regulatory agencies to conceal risks associated with their products. Granting these companies immunity from liability would remove a critical check on corporate misconduct, endanger public health, and prevent exposure of fraudulent practices that litigation has historically uncovered.
This document cites concerns against granting legal immunity to ChemChina, a Chinese military-affiliated company, for pesticide-related harms, particularly those linked to paraquat, which is banned in many countries but still sold in the U.S. It warns that such immunity would prevent American farmers from seeking justice for health risks like Parkinson’s disease and undermine national security by protecting a foreign military-controlled corporation from accountability.